Literature DB >> 24724880

Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.

Dayong Lee1, Jennifer R Schroeder, Erin L Karschner, Robert S Goodwin, Jussi Hirvonen, David A Gorelick, Marilyn A Huestis.   

Abstract

OBJECTIVES: Chronic, frequent cannabis smokers may experience residual and offset effects, withdrawal, and craving when abstaining from the drug. We characterized the prevalence, duration, and intensity of these effects in chronic frequent cannabis smokers during abstinence on a closed research unit.
METHODS: Non-treatment-seeking participants (N = 29 on admission, 66% and 34% remaining after 2 and 4 weeks) provided subjective effects data. A battery of five instruments was computer-administered daily to measure psychological, sensory, and physical symptoms associated with cannabinoid intoxication and withdrawal. Plasma and oral fluid specimens were concurrently collected and analyzed for cannabinoids. Outcome variables were evaluated as change from admission (Day 0) with regression models.
RESULTS: Most abstinence effects, including irritability and anxiety were greatest on Days 0-3 and decreased thereafter. Cannabis craving significantly decreased over time, whereas decreased appetite began to normalize on Day 4. Strange dreams and difficulty getting to sleep increased over time, suggesting intrinsic sleep problems in chronic cannabis smokers. Symptoms likely induced by residual drug effects were at maximum intensity on admission and positively correlated with plasma and oral fluid cannabinoid concentrations on admission but not afterward; these symptoms showed overall prevalence higher than cannabis withdrawal symptoms.
CONCLUSIONS: The combined influence of residual/offset drug effects, withdrawal, and craving was observed in chronic cannabis smokers during monitored abstinence. Abstinence symptoms were generally more intense in the initial phase, implying importance of early intervention in cannabis quit attempts. Sleep disturbance persisting for an extended period suggests that hypnotic medications could be beneficial in treating cannabis dependence. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24724880      PMCID: PMC3986824          DOI: 10.1111/j.1521-0391.2014.12088.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  34 in total

1.  Diagnostic criteria for cannabis withdrawal syndrome.

Authors:  David A Gorelick; Kenneth H Levin; Marc L Copersino; Stephen J Heishman; Fang Liu; Douglas L Boggs; Deanna L Kelly
Journal:  Drug Alcohol Depend       Date:  2011-12-07       Impact factor: 4.492

2.  Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

Authors:  David M Schwope; Erin L Karschner; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2011-08-11       Impact factor: 8.327

3.  Marijuana Craving Questionnaire: development and initial validation of a self-report instrument.

Authors:  S J Heishman; E G Singleton; A Liguori
Journal:  Addiction       Date:  2001-07       Impact factor: 6.526

4.  Cannabinoid disposition in oral fluid after controlled smoked cannabis.

Authors:  Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-01-24       Impact factor: 8.327

5.  The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress.

Authors:  David J Allsop; Melissa M Norberg; Jan Copeland; Shanlin Fu; Alan J Budney
Journal:  Drug Alcohol Depend       Date:  2011-07-02       Impact factor: 4.492

6.  Marijuana withdrawal among adults seeking treatment for marijuana dependence.

Authors:  A J Budney; P L Novy; J R Hughes
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

7.  Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.

Authors:  J Hirvonen; R S Goodwin; C-T Li; G E Terry; S S Zoghbi; C Morse; V W Pike; N D Volkow; M A Huestis; R B Innis
Journal:  Mol Psychiatry       Date:  2011-07-12       Impact factor: 15.992

8.  Abstinence symptoms during withdrawal from chronic marijuana use.

Authors:  E M Kouri; H G Pope
Journal:  Exp Clin Psychopharmacol       Date:  2000-11       Impact factor: 3.157

9.  Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis.

Authors:  David M Schwope; Wendy M Bosker; Johannes G Ramaekers; David A Gorelick; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2012-05-15       Impact factor: 3.367

10.  Quantifying the clinical significance of cannabis withdrawal.

Authors:  David J Allsop; Jan Copeland; Melissa M Norberg; Shanlin Fu; Anna Molnar; John Lewis; Alan J Budney
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more
  12 in total

Review 1.  Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI.

Authors:  Hudaisa Fatima; Allyn C Howlett; Christopher T Whitlow
Journal:  Br J Radiol       Date:  2019-08-09       Impact factor: 3.039

Review 2.  Screening Medications for the Treatment of Cannabis Use Disorder.

Authors:  L V Panlilio; Z Justinova; J M Trigo; B Le Foll
Journal:  Int Rev Neurobiol       Date:  2016-03-10       Impact factor: 3.230

3.  Differential Effects of Addictive Drugs on Sleep and Sleep Stages.

Authors:  Harold W Gordon
Journal:  J Addict Res (OPAST Group)       Date:  2019-07-15

4.  Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study.

Authors:  Jordan P Davis; Douglas C Smith; Jason W Morphew; Xinrong Lei; Saijun Zhang
Journal:  J Drug Issues       Date:  2016-01

5.  Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults.

Authors:  LaTrice Montgomery; Erin A McClure; Rachel L Tomko; Susan C Sonne; Theresa Winhusen; Garth E Terry; Jason T Grossman; Kevin M Gray
Journal:  Drug Alcohol Depend       Date:  2019-03-14       Impact factor: 4.492

Review 6.  Psychosocial interventions for cannabis use disorder.

Authors:  Peter J Gates; Pamela Sabioni; Jan Copeland; Bernard Le Foll; Linda Gowing
Journal:  Cochrane Database Syst Rev       Date:  2016-05-05

7.  Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.

Authors:  Nicolas J Schlienz; Alan J Budney; Dustin C Lee; Ryan Vandrey
Journal:  Curr Addict Rep       Date:  2017-04-29

8.  Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain.

Authors:  Lara N Coughlin; Mark A Ilgen; Mary Jannausch; Maureen A Walton; Kipling M Bohnert
Journal:  Addiction       Date:  2021-01-06       Impact factor: 7.256

Review 9.  ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework.

Authors:  Udi E Ghitza
Journal:  Front Psychiatry       Date:  2014-12-08       Impact factor: 4.157

Review 10.  Establishing legal limits for driving under the influence of marijuana.

Authors:  Kristin Wong; Joanne E Brady; Guohua Li
Journal:  Inj Epidemiol       Date:  2014-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.